Development of a novel luminol-related compound, 3-propyl-7,8-dihydropyridazino-[4,5-g]quinoxaline-2,6,9(1H)- trione, and its application to hydrogen peroxide and serum glucose assays.
Manual and flow injection methods with chemiluminescence detection were developed for the determination of hydrogen peroxide (H2O2) using a novel luminol-related compound, 3-propyl-7,8-dihydropyridazino[4,5-g]quinoxaline-2,6,9(1H)-trione (PDIQ), having a higher efficiency than luminol. The methods are based on the chemiluminescence produced by the reaction of H2O2 with PDIQ in the presence of microperoxidase in alkaline media. Detection limits for manual and flow injection methods are 13 pmol per 100 microliter of test solution and 1.3 pmol per 100 microliter injection volume, respectively, at a ratio of chemiluminescence intensities (or peak heights) of test to blank of 2. The manual method was applied to the determination of glucose in human serum. The method correlated well with the conventional spectrophotometric method (4 = 0.998).
Ishida
J
J
Faculty of Pharmaceutical Sciences, Fukuoka University, Japan.
Arakawa
H
H
Takada
M
M
Yamaguchi
M
M
D001786:Blood Glucose / Q000032:analysis*; D003920:Diabetes Mellitus / Q000097:blood; D006801:Humans; D006861:Hydrogen Peroxide / Q000097:blood*; D008165:Luminol / Q000737:chemistry*; D011810:Quinoxalines / Q000737:chemistry*
C093938:3-propyl-7,8-dihydropyridazino(4,5-g)quinoxaline-2,6,9(1H)-trione; D001786:Blood Glucose; D011810:Quinoxalines; D008165:Luminol; D006861:Hydrogen Peroxide